Evidence map›Paper›PMID 38610738›Full record

ReviewJournal of clinical medicine2024

Proton Pump Inhibitors and Cancer Risk: A Comprehensive Review of Epidemiological and Mechanistic Evidence.

Ibrahim O Sawaid, Abraham O Samson

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
14.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Virulence · 2025
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Immune Basis of Therapeutic Effects ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  19. Serendipity in Neuro-Oncology: The Evolution of Chemotherapeutic Agents.International journal of molecular sciences · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ibrahim O SawaidAzrieli Faculty of Medicine, Bar Ilan University, Safed 1311502, Israel.
Abraham O SamsonAzrieli Faculty of Medicine, Bar Ilan University, Safed 1311502, Israel.ORCID 0000-0001-7436-3515
Bar-Ilan University · IL

Funding

Ginsberg Foundation Ginsberg Foundation qKatz foundation Katz foundation 1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CCKB2R—cholecystokinin B2 receptorECL cells—enterochromaffin-like cellsGERD—gastroesophageal reflux diseaseGI—gastrointestinalH2RB—H2R blockerH2R—histamine H2 receptorHelicobacter pylori—H. pyloriNET—neuroendocrine tumorPPI—proton pump inhibitor

Identifiers

PMID38610738
PMCPMC11012754
OpenAlexW4393279407

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.